Vaccine News and Research

Latest Vaccine News and Research

Chiron has received a license for its new meningococcal B vaccine for New Zealand

Chiron developed the vaccine, in close collaboration with the New Zealand Ministry of Health and the Norwegian Institute of Public Health, to protect against the specific meningococcal B strain responsible for a 13-year epidemic in the country.

7 Jul 2004

The impact of rotavirus on the world’s children

With vaccines against the killer disease of rotavirus almost in hand, government representatives, scientists, public health professionals and vaccine industry representatives will be convened in Mexico City to review progress toward safe, effective rotavirus vaccines and address the question of how to make sure they get to the world’s poorest children

7 Jul 2004

Extension of vaccination programs against anthrax to include U.S. forces in the Pacific Commands including Korea

William Winkenwerder, Jr., MD, assistant secretary of defense for health affairs has announced the extension of the vaccination programs against anthrax to include U.S. forces in the Pacific Commands including Korea.

4 Jul 2004

Reports of a serious polio outbreak among children in Rogo, Nigeria

Reports of a serious polio outbreak among children in Rogo, Kano State, have emerged. Kano is Nigeria's most populous northern state.

2 Jul 2004

Pneumococcal vaccination now free in Ontario

The pneumococcal vaccination, the first of three new free child vaccines being introduced by the McGuinty government, is now available, Health and Long-Term Care Minister George Smitherman announced today.

2 Jul 2004

Fall in the number of confirmed cases of Haemophilus influenzae type b (Hib) disease

A Health Protection Agency study has shown a sharp fall in the number of confirmed cases of Haemophilus influenzae type b (Hib) disease following the introduction of a Department of Health booster campaign, the Agency’s Board heard today.

2 Jul 2004

ASU and Mayo Clinic collaborate on a new joint nursing program

ASU and Mayo Clinic have reached an agreement to collaborate on a new joint nursing program based at Mayo Clinic Hospital in northeast Phoenix.

2 Jul 2004

Nigeria resuming polio immunization

The World Health Organization (WHO) has been informed by the Governor of Kano, Nigeria, of the intention to resume polio immunization campaigns there in early July.

30 Jun 2004

Harmless form of the herpes virus may help create a vaccine for Alzheimer’s disease

Scientists have taken an important step toward creating a vaccine against Alzheimer’s disease, customizing the response of the immune system with unprecedented precision.

30 Jun 2004

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Oxford University's Therapeutic Antibody Centre (TAC) has received a Manufacturer's Authorisation (Investigational Medicinal Products) from the Medicines and Healthcare Products Regulatory Agency (MHRA).

29 Jun 2004

New £18M Medical Research Council facility

A new £18M Medical Research Council (MRC) facility to understand and compare the genetics of disease in mice and humans will be opened today, Wednesday 30 June, by Lord Sainsbury, Minister for Science and Technology.

29 Jun 2004

12 sites testing a new vaccine to prevent anthrax

The phase II trial will evaluate the safety and immunogenic response of a new recombinant anthrax vaccine, known as rPA102. The vaccine candidate consists of recombinant Protective Antigen (rPA), a synthetic protein that induces antibodies designed to prevent illness by neutralizing anthrax toxins, and aluminum hydroxide to enhance the immune response.

29 Jun 2004

UK launch of The Institute of Medical Law

The University of Birmingham is continuing to lead the way in international research into medical-legal issues such as MMR, euthanasia and drug regulation with the launch of The Institute of Medical Law.

29 Jun 2004

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

Viruses’ growing resistance to drugs means diseases such as hepatitis B and C are increasingly difficult to treat. New pandemics may arise with unforeseeable consequences.

29 Jun 2004

A viral respiratory infection common in children increases the risk of developing asthma

The study, published in The Journal of Infectious Diseases, is the first to show a link between respiratory syncytial virus, or RSV, infection and asthma in mice. A related study, also in mice, suggests that a medication neutralizing the virus could decrease children's chances of developing asthma.

28 Jun 2004